|Elective cancer surgery in COVID-19–free surgical pathways during the SARS-CoV-2 pandemic: an international, multicenter, comparative cohort study|
JC Glasbey, D Nepogodiev, JFF Simoes, O Omar, E Li, ML Venn, ...
Journal of Clinical Oncology 39 (1), 66, 2021
|Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium|
P Grivas, AR Khaki, TM Wise-Draper, B French, C Hennessy, CY Hsu, ...
Annals of oncology 32 (6), 787-800, 2021
|Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19|
MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, ...
JAMA oncology 7 (8), 1167-1175, 2021
|Cellular heterogeneity profiling by hyaluronan probes reveals an invasive but slow-growing breast tumor subset|
M Veiseh, DH Kwon, AD Borowsky, C Tolg, HS Leong, JD Lewis, ...
Proceedings of the National Academy of Sciences 111 (17), E1731-E1739, 2014
|Racial disparities in COVID-19 outcomes among black and white patients with cancer|
J Fu, SA Reid, B French, C Hennessy, C Hwang, NT Gatson, N Duma, ...
JAMA network open 5 (3), e224304-e224304, 2022
|Ethnic disparities among men with prostate cancer undergoing germline testing|
DHM Kwon, HT Borno, HH Cheng, AY Zhou, EJ Small
Urologic Oncology: Seminars and Original Investigations 38 (3), 80. e1-80. e7, 2020
|Association between androgen deprivation therapy and mortality among patients with prostate cancer and COVID-19|
AL Schmidt, MD Tucker, Z Bakouny, C Labaki, CY Hsu, Y Shyr, ...
JAMA network open 4 (11), e2134330-e2134330, 2021
|TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor|
I de Kouchkovsky, L Zhang, EJ Philip, F Wright, DM Kim, D Natesan, ...
Journal for immunotherapy of cancer 9 (5), 2021
|Improving research for prostate cancer survivorship: A statement from the Survivorship Research in Prostate Cancer (SuRECaP) working group|
V Narayan, M Harrison, H Cheng, S Kenfield, R Aggarwal, D Kwon, ...
Urologic Oncology: Seminars and Original Investigations 38 (3), 83-93, 2020
|Immunogenic priming with 177Lu-PSMA-617 plus pembrolizumab in metastatic castration resistant prostate cancer (mCRPC): A phase 1b study.|
RR Aggarwal, S Luch Sam, VS Koshkin, EJ Small, FY Feng, ...
Journal of Clinical Oncology 39 (15_suppl), 5053-5053, 2021
|Changes in cancer management due to COVID-19 illness in patients with cancer in Northern California|
JTY Wu, DH Kwon, MJ Glover, S Henry, D Wood, DL Rubin, VS Koshkin, ...
JCO oncology practice 17 (3), e377-e385, 2021
|Androgen-deprivation therapy and SARS-CoV-2 in men with prostate cancer: findings from the University of California Health System registry|
DH Kwon, R Vashisht, HT Borno, RR Aggarwal, EJ Small, AJ Butte, ...
Annals of Oncology 32 (5), 678-679, 2021
|Periprocedural management of patients undergoing liver resection or embolotherapy for neuroendocrine tumor metastases|
DH Kwon, A Paciorek, CK Mulvey, H Chan, N Fidelman, L Meng, ...
Pancreas 48 (4), 496-503, 2019
|Physician‐reported barriers to referring cancer patients to specialists: Prevalence, factors, and association with career satisfaction|
DH Kwon, DM Tisnado, NL Keating, CN Klabunde, JL Adams, A Rastegar, ...
Cancer 121 (1), 113-122, 2015
|Interplay of immunosuppression and immunotherapy among patients with cancer and COVID-19|
Z Bakouny, C Labaki, P Grover, J Awosika, S Gulati, CY Hsu, ...
JAMA oncology 9 (1), 128-134, 2023
|Differential treatment outcomes in BRCA1/2‐, CDK12‐, and ATM‐mutated metastatic castration‐resistant prostate cancer|
DH Kwon, J Chou, SM Yip, MA Reimers, L Zhang, F Wright, MS Dhawan, ...
Cancer 127 (12), 1965-1973, 2021
|Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19|
SM Rubinstein, D Bhutani, RC Lynch, CY Hsu, Y Shyr, S Advani, ...
Blood cancer discovery 3 (3), 181-193, 2022
|Gastric neuroendocrine tumors: management and challenges|
DH Kwon, EK Nakakura, EK Bergsland, SC Dai
Gastrointestinal Cancer: Targets and Therapy, 31-37, 2017
|Coinfections in patients with cancer and COVID-19: a COVID-19 and cancer consortium (CCC19) study|
G Satyanarayana, KT Enriquez, T Sun, EJ Klein, M Abidi, SM Advani, ...
Open forum infectious diseases 9 (3), ofac037, 2022
|The impact of androgen deprivation therapy on COVID-19 illness in men with prostate cancer|
NJ Shah, VG Patel, X Zhong, L Pina, JE Hawley, E Lin, BA Gartrell, ...
JNCI cancer spectrum 6 (3), pkac035, 2022